Personalized therapy and pharmacogenomics: future perspective

Pharmacogenomic genome-wide association studies: lessons learned thus far

(2009) James J Crowley et al.   PHARMACOGENOMICS

Pharmacogenomics of adverse drug reactions: practical applications and perspectives

(2009) Laurent Becquemont   PHARMACOGENOMICS

Systems biology in pharmacogenomic research: the way to personalized prescribing?

(2009) Ellen S Koster et al.   PHARMACOGENOMICS

CYP4F2 genetic variant (rs2108622) significantly contributes to warfarin dosing variability in the Italian population

(2009) Paola Borgiani et al.   PHARMACOGENOMICS

A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose

(2008) G. M. Cooper et al.   BLOOD

Effect of CYP3A5*3 genotype on the pharmacokinetics and antiplatelet effect of clopidogrel in healthy subjects

(2008) Kyoung-Ah Kim et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Pharmacogenomics of Cardiovascular Pharmacology: Molecular Network Analysis in Pleiotropic Effects of Statin — an Experimental Elucidation of the Pharmacologic Action From Protein-Protein Interaction Analysis

(2008) Masayuki Shiota et al.   JOURNAL OF PHARMACOLOGICAL SCIENCES

SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study

(2008)   NEW ENGLAND JOURNAL OF MEDICINE

Polymorphisms affecting gene transcription and mRNA processing in pharmacogenetic candidate genes: detection through allelic expression imbalance in human target tissues

(2008) Andrew D. Johnson et al.   Pharmacogenetics and Genomics

Pharmacogenomic Biomarker Information in Drug Labels Approved by the United States Food and Drug Administration: Prevalence of Related Drug Use

(2008) Felix W Frueh et al.   PHARMACOTHERAPY